// App-Quantinova.ai

1154-334 : VALIDATION OF THE APIXABAN COST-EFFECTIVENESS MODEL IN PATIENTS WITH VENOUS THROMBOEMBOLISM

Researchers

Presenter

  • Tereza Lanitis

Principal Investigators

  • Melissa Hamilton

  • Dale Rublee

  • Chantelle Browne

  • Robert Leipold

  • Peter Quon

  • Cristina Masseria

  • Alexander Cohen

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • apixaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved